Indian business news
Friday, December 18, 2020
Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals
Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
from NDTV Profit - Latest https://ift.tt/3oWDibU
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment